Cara Therapeutics Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
3,963.00
17,745.00
24,690.00
57,280.00
58,125.00
74,013
Depreciation, Depletion & Amortization
789.00
783.00
839.00
1,465.00
495.00
370
Other Funds
3,572.00
1,106.00
2,209.00
2,445.00
5,850.00
8,123
Funds from Operations
398.00
15,856.00
21,642.00
53,370.00
51,780.00
65,520
Changes in Working Capital
2,431.00
1,786.00
164.00
5,989.00
3,047.00
43,219
Net Operating Cash Flow
2,829.00
17,642.00
21,478.00
47,381.00
54,827.00
22,301
Capital Expenditures
5.00
42.00
20.00
717.00
58.00
Sale of Fixed Assets & Businesses
-
-
-
-
41.00
Purchase/Sale of Investments
-
-
91,657.00
44,966.00
36,483.00
Net Investing Cash Flow
5.00
42.00
91,677.00
44,249.00
36,500.00
Issuance/Reduction of Debt, Net
774.00
-
-
-
-
Net Financing Cash Flow
8,416.00
57,990.00
75,593.00
123.00
87,923.00
Net Change in Cash
11,240.00
40,306.00
37,562.00
3,009.00
3,404.00
Free Cash Flow
2,824.00
17,684.00
21,498.00
48,098.00
54,885.00
Change in Capital Stock
7,642.00
57,990.00
75,593.00
123.00
87,923.00
About Cara Therapeutics
View Profile
